All Clinical Trials

A listing of 23130 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Trials

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Trial

Studying an Investigational Virus Vaccine

Recruiting

The main objectives of this study are to assess the safety and effectiveness of an investigational vaccine aimed at preventing norovirus, commonly known as the stomach flu. Participants will be randomly assigned to receive either the investigational vaccine or a placebo. Should you express interest, you will be contacted directly by the research site, which will provide further details and answer any questions you may have about study requirements, risks/benefits, and any compensation.

Conditions:

Healthy

Interested in vaccine studies

All Conditions

Preventative Trials

Learn More

Featured Trial

Type 2 Diabetes Clinical Trial

Recruiting

Can changing your breakfast improve your type 2 diabetes? If you have an HbA1C of 7.0% or higher, you are invited to participate in an online study at the University of Michigan.

Conditions:

Type 2 Diabetes

Diabetes Mellitus Type 2 in Obese

Diabetes Type Two

Type 2 Diabetes Mellitus

Diabete Type 2

Learn More

Featured Trial

Evaluating an Investigational Treatment for Hidradenitis Suppurativa

Recruiting

The main objectives of this Phase 2 study are to evaluate the safety and effectiveness of an investigational medication in adults with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition. Participants will be randomly assigned to receive the investigational treatment or a placebo. Should you express interest, the research site will contact you directly to provide further details and address any questions you may have about study requirements, risks/benefits, and compensation.

Conditions:

All Conditions

Hidradenitis suppurativa (Skin disorder)

Dermatology

Learn More

Featured Trial

Crohn's Disease Clinical Study

Recruiting

Help us study a potential new way to treat Crohn's disease. We are seeking adults living with Crohn's disease to join our latest clinical trial to help us learn more. Eligible participants will receive study-related treatment, assessments, and care at no cost. You will also receive reimbursement for travel while participating. Health insurance is not required to take part.

Conditions:

Crohn's Disease

Crohn Disease

Crohns Disease

Crohn's Disease (CD)

Crohn Colitis

Learn More

Featured Trial

Studying an Investigational Medication's Impact on Cardiovascular Events

Recruiting

The main objectives of this Phase 3 study are to evaluate the safety and effectiveness of an investigational medication's ability to reduce major adverse cardiovascular events (such as heart attacks and strokes) in adults at risk. Participants will be randomly assigned to receive either the investigational medication or a placebo. Should you express interest, you will be contacted directly by the research site, which will provide further details and answer any questions you may have about study requirements, risks/benefits, and any compensation.

Conditions:

All Conditions

Hyperlipidemia

Cardiovascular Disease

Ischemic heart disease (IHD)

Stroke

Learn More

Genetic and Physical Study of Childhood Nerve and Muscle Disorders

NCT01568658

Recruiting

Background: - Some nerve and muscle disorders that start early in life (before age 25), like some forms of muscular dystrophy, can run in families. However, the genetic causes of these disorders are not known. Also, doctors do not fully understand how symptoms of these disorders change over time. Researchers want to learn more about genetic nerve and muscle disorders that start in childhood by studying affected people and their family members, as well as healthy volunteers. Objectives: - To better understand nerve and muscle disorders that start early in life and run in families. Eligibility: * Individuals at least 4 weeks old with childhood-onset muscular and nerve disorders, including those who have a later onset of a disorder that typically has childhood onset. * Affected and unaffected family members of the individuals with muscular and nerve disorders. * Healthy volunteers at least 4 weeks old with no nerve or muscle disorders. Design: * Participants will be screened with a physical exam and medical history. Genetic information will be collected from blood, saliva, cheek swab, or skin samples. Urine samples may also be collected. * Healthy volunteers and unaffected family members will have imaging studies of the muscles. These studies will include magnetic resonance imaging (MRI) and ultrasound scans. Results will be compared with those from the affected participants. * All participants with nerve and muscle disorders will have multiple tests, including the following: * Imaging studies of the muscles, including ultrasound and MRI scans. * Imaging studies of the bones, such as x-rays and DEXA scans. * Heart and lung function tests. * Eye exams. * Nerve and muscle electrical activity tests and biopsies. * Video and photo image collection of affected muscles. * Speech, language, and swallowing evaluation. * Lumbar puncture to collect spinal fluid for study. * Tests of movement, attention, thinking, and coordination. * Participants with nerve and muscle disorders will return to the Clinical Center every year. They will repeat the tests and studies at these visits. Read Less

Gender:

ALL

Ages:

Between 1 day and 100 years

Trial Updated:

04/10/2025

Locations: National Institutes of Health Clinical Center, Bethesda, Maryland

Conditions: Muscular Dystrophies, Muscle Myopathies, Hereditary Spastic Paraplegias, Inherited Neuropathies, Inherited Neuromuscular Conditions

Learn More ›

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR

NCT03142152

Recruiting

The objective of this prospective, randomized, blinded clinical trial is to assess the safety and efficacy of the Carillon Mitral Contour System in treating heart failure with functional regurgitation (FMR).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/10/2025

Locations: Dignity Health Research Institute at Mercy Gilbert and Chandler Regional Medical Centers, Gilbert, Arizona +68 locations

Dignity Health Research Institute at Mercy Gilbert and Chandler Regional Medical Centers, Gilbert, Arizona

Banner Health - Phoenix, Phoenix, Arizona

Tucson Medical Center Health, Tucson, Arizona

Banner University Tuscon, Tucson, Arizona

Memorial Care Hospital, Long Beach, California

Keck School of Medicine of USC, Los Angeles, California

UCLA Medical Center, Los Angeles, California

Stanford University, Redwood City, California

Scripps Health, San Diego, California

University of California- San Francisco, San Francisco, California

South Denver Cardiology, Littleton, Colorado

Medstar, Washington, District of Columbia

University of Miami, Miami, Florida

Advent Health Hospital, Orlando, Florida

Palm Beach Gardens Medical, Palm Beach, Florida

Tallahassee Research Institute, Tallahassee, Florida

Tampa General Hospital, Tampa, Florida

Augusta University Research Institute, Augusta, Georgia

Wellstar Health System,, Marietta, Georgia

Advocate Good Samaritan, Downers Grove, Illinois

Midwest Cardiovascular Institute (MCI), Naperville, Illinois

Prairie Heart Institute, Springfield, Illinois

Community Health Network, Indianapolis, Indiana

Cardiovascular Institute South, Houma, Louisiana

Ochsner Health System, New Orleans, Louisiana

Johns Hopkins, Baltimore, Maryland

St. Elizabeths, Boston, Massachusetts

Massachusetts General Hospital, Boston, Massachusetts

Beth Israel Deaconess, Boston, Massachusetts

University of Michigan, Ann Arbor, Michigan

Ascension St. Marys Research Institute, Saginaw, Michigan

CentraCare Heart and Vascular, Saint Cloud, Minnesota

Deborah Heart & Lung, Browns Mills, New Jersey

Hackensack University Medical Center, Edison, New Jersey

Albany Medical College,, Albany, New York

University at Buffalo, Buffalo, New York

Vassar Brothers- Hudson Valley Cardiovascular Practice, Poughkeepsie, New York

Lindner Research Center at the Christ Hospital, Cincinnati, Ohio

Harrington Vascular, Cleveland, Ohio

Cleveland Clinic, Cleveland, Ohio

The Ohio State University, Columbus, Ohio

Kettering Health Research Institute, Dayton, Ohio

Oklahoma Heart Institute Hospital, Tulsa, Oklahoma

Saint Francis Hospital,, Tulsa, Oklahoma

Oregon Health & Science University (OHSU), Portland, Oregon

Providence Heart Institute, Portland, Oregon

Geisinger Medical Center, Danville, Pennsylvania

Penn Medicine Lancaster General Health, Lancaster, Pennsylvania

University of Pennsylvania, Philadelphia, Pennsylvania

Thomas Jefferson University, Philadelphia, Pennsylvania

Allegheny Health Network, Pittsburgh, Pennsylvania

Lankenau Institute of Medical Research, Wynnewood, Pennsylvania

North Central Heart-Avera, Sioux Falls, South Dakota

Centennial Medical Center, Nashville, Tennessee

Henrico Doctors Hospital, Henrico, Virginia

Carilion Hospital, Roanoke, Virginia

Advocate Aurora Research Institute, Milwaukee, Wisconsin

University of Alberta, Edmonton, Alberta

St Boniface Hospital - University of Manitoba, Winnipeg, Manitoba

Toronto General Hospital, Toronto, Ontario

Unity Health Toronto, St Michael's Hospital, Toronto, Ontario

Pole Sante Republique, Clermont Ferrand, Not set

Centre Hospitalier Universitaire De Lille, Lille, Not set

Hôpital Cardiologique Louis Pradel, Lyon, Not set

Clinique du Millènaire Montpelier, Montpelier, Not set

Hôpital Européen Georges-Pompidou, Paris, Not set

European Interbalkan Medical Center, Thessaloníki, Not set

Poznan University of Medical Sciences, Poznan, Not set

St James University Hospital, Leeds, Not set

Conditions: Functional Mitral Regurgitation, Heart Failure, Mitral Valve Insufficiency, Heart Diseases, Cardiovascular Diseases, Heart Valve Diseases

Learn More ›

Men at High Genetic Risk for Prostate Cancer

NCT03805919

Recruiting

Background: Research studies have shown that genetic changes and family history may increase a man s risk for prostate cancer. Researchers want to follow the prostate health of men who have specific genetic changes associated with prostate cancer to help them learn more about which men are at higher risk for prostate cancer. Objectives: To study men with specific genetic changes and determine who is at higher risk for getting prostate cancer. To study if certain genetic changes and family his... Read More

Gender:

MALE

Ages:

Between 30 years and 75 years

Trial Updated:

04/10/2025

Locations: National Institutes of Health Clinical Center, Bethesda, Maryland

Conditions: Prostatic Neoplasms

Learn More ›

Dietary Behavior Intervention in African Americans at Risk for Cardiovascular Disease

NCT04305431

Recruiting

Background: The risk of heart disease among African Americans is still common despite a greater understanding of the disease and better approaches to managing it. Healthy cooking and eating patterns can help reduce the risk of heart disease. But things like access to grocery stores and knowledge of good nutrition can affect these healthy patterns. Researchers want to see if community-based programs can help. Objective: To learn about the cooking behaviors of African American adults at risk fo... Read More

Gender:

ALL

Ages:

Between 18 years and 99 years

Trial Updated:

04/10/2025

Locations: National Institutes of Health Clinical Center, Bethesda, Maryland

Conditions: Diet, Cooking

Learn More ›

Pfizer-BioNTech COVID-19 Vaccine Effectiveness Study - Kaiser Permanente Southern California

NCT04848584

Recruiting

The primary objective of this study is to determine the vaccine effectiveness of 2 doses of Pfizer-BioNTech BNT162b2 vaccine against COVID-19-associated hospitalization. There will be a large retrospective database study using two parallel study designs: a test-negative case-control design and a retrospective cohort design. VE estimates by various strata and strain type will be conducted.

Gender:

ALL

Ages:

0 years and above

Trial Updated:

04/10/2025

Locations: Kaiser Permanente Southern California, Pasadena, California

Conditions: COVID-19

Learn More ›

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

NCT05006716

Recruiting

Study consists of two main parts to explore BGB-16673 recommended dosing, a Phase 1 monotherapy dose finding comprised of monotherapy dose escalation and monotherapy safety expansion of selected doses, and a Phase 2 (expansion cohorts)

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/10/2025

Locations: University of Alabama At Birmingham Hospital, Birmingham, Alabama +118 locations

University of Alabama At Birmingham Hospital, Birmingham, Alabama

Western Regional Medical Center, Llc, Goodyear, Arizona

Mayo Clinic Phoenix, Phoenix, Arizona

Honor Health Research Institute, Scottsdale, Arizona

University of Arizona Cancer Center, Tucson, Arizona

University of California San Diego (Ucsd) Moores Cancer Center, La Jolla, California

Stanford Medicine, Palo Alto, California

UCLA Santa Monica Cancer Care, Santa Monica, California

Uchealth North, Fort Collins, Colorado

Mayo Clinic Jacksonville, Jacksonville, Florida

Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida

Tampa General Hospital Cancer Institute, Tampa, Florida

Augusta University, Augusta, Georgia

Southeastern Regional Medical Center, Newnan, Georgia

Midwestern Regional Medical Center, Zion, Illinois

University of Iowa Hospitals and Clinics, Iowa City, Iowa

Norton Cancer Institute Pavilion, Louisville, Kentucky

Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana

American Oncology Partners of Maryland Pa, Bethesda, Maryland

Dana Farber Cancer Institute, Boston, Massachusetts

Karmanos Cancer Institute, Detroit, Michigan

Mayo Clinic Rochester, Rochester, Minnesota

Nebraska Cancer Specialists, Omaha, Nebraska

Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada

Summit Medical Group, Florham Park, New Jersey

Roswell Park Comprehensive Cancer Center, Buffalo, New York

Columbia University Medical Center, New York, New York

Weill Cornell Medical College Newyork Presbyterian Hospital, New York, New York

Memorial Sloan Kettering Cancer Center Mskcc, New York, New York

Tennesse Oncology Chattanooga, Chattanooga, Tennessee

Tennessee Oncology, Pllc Nashville, Nashville, Tennessee

Md Anderson Cancer Center, Houston, Texas

Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia

Fred Hutchinson Cancer Research Center, Seattle, Washington

Concord Repatriation General Hospital, Concord, New South Wales

Calvary Mater Newcastle, Waratah, New South Wales

Princess Alexandra Hospital, Woolloongabba, Queensland

St Vincents Hospital Melbourne, Fitzroy, Victoria

Peninsula Private Hospital, Frankston, Victoria

Austin Health, Heidelberg, Victoria

Peter Maccallum Cancer Centre, Melbourne, Victoria

The Alfred Hospital, Melbourne, Victoria

Linear Clinical Research, Nedlands, Western Australia

Perth Blood Institute, West Perth, Western Australia

Hospital Sirio Libanes Brasilia, Brasilia, Not set

Instituto de Pesquisa Em Saude Da Universidade de Caxias Do Sul, Caxias do Sul, Not set

Hospital Erasto Gaertner, Curitiba, Not set

Centro Gaucho Integrado de Oncologia Hospital Mae de Deus, Porto Alegre, Not set

Hospital Ernesto Dornelles, Porto Alegre, Not set

Real E Benemerita Associacao Portuguesa de Sao Paulo, Sao Paulo, Not set

Hospital Alemao Oswaldo Cruz, Sao Paulo, Not set

Hospital Nove de Julho Dasa, Sao Paulo, Not set

Instituto Dor de Pesquisa E Ensino Sao Paulo, Sao Paulo, Not set

Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, Sao Paulo, Not set

Hospital Santa Rita de Cassia Afecc, Vitoria, Not set

Cross Cancer Institute, Edmonton, Alberta

British Columbia Cancer Agency the Vancouver Centre, Vancouver, British Columbia

Princess Margaret Cancer Centre, Toronto, Ontario

Arthur Je Child Comprehensive Cancer Centre, Calgary, Not set

Chu de Quebec Universite Laval, Hopital de Lenfant Jesus, Centre Integre de Cancerologie (Cic), Quebec, Not set

Centre de Lutte Contre Le Cancer Institut Bergonie, Bordeaux, Not set

Hopital Estaing, Clermontferrand, Not set

Chu Henri Mondor, Creteil, Not set

Hopital Claude Huriez Chu Lille, Lille, Not set

Centre Leon Berard, Lyon Cedex, Not set

Institut Paoli Calmettes, Marseille, Not set

Chu Montpellier Hopital Saint Eloi, Montpellier, Not set

Hopital de La Pitie Salpetriere, Paris, Not set

Centre Henri Becquerel, Rouen Cedex, Not set

Arensia Exploratory Medicine Llc, Tbilisi, Not set

Universitatsklinikum Carl Gustav Carus An Der Technischen Universitat Dresden, Dresden, Not set

Uniklinik Koln (Aor), Koln, Not set

Universitares Krebszentrum Leipzig, Leipzig, Not set

Universitaetsklinikum Schleswig Holstein Campus Luebeck, Luebeck, Not set

Klinikum Johannes Gutenberg Universitaet Mainz, Mainz, Not set

Klinikum Grosshadern Ludwig Maximilians Universitat Munchen, Munchen, Not set

Universitaetsklinikum Ulm, Ulm, Not set

Policlinico Sorsola Malpighi, Aou Di Bologna, Bologna, Not set

Ospedale San Raffaele, Milano, Not set

Istituto Europeo Di Oncologia, Milano, Not set

Niguarda Cancer Center Division of Hematology, Milano, Not set

Fondazione Policlinico Universitario Agostino Gemelli, Roma, Not set

Centroricerche Cliniche Di Verona Srl, Verona, Not set

Aichi Cancer Center Hospital Clinical Oncology, Nagoya, Aichi

Chiba Cancer Center, Chibashi, Chiba

National Cancer Center Hospital East, Kashiwa, Chiba

Cancer Institute Hospital of Jfcr, Kotoku, Tokyo

Yokohama Municipal Citizens Hospital, YokohamaShi, Not set

Inje University Busan Paik Hospital, BusanjinGu, Busan Gwang'yeogsi

Samsung Medical Center, GangnamGu, Seoul Teugbyeolsi

The Catholic University of Korea, Seoul St Marys Hospital, SeochoGu, Seoul Teugbyeolsi

Severance Hospital Yonsei University Health System, SeodaemunGu, Seoul Teugbyeolsi

Seoul National University Hospital, Seoul, Seoul Teugbyeolsi

Asan Medical Center, SongpaGu, Seoul Teugbyeolsi

Pusan National University Hospital, SeoGu, Not set

The Institute of Oncology, Arensia Exploratory Medicine, Chisinau, Not set

Hospital Universitario Vall Dhebron, Barcelona, Not set

Hospital de La Santa Creu I Sant Pau, Barcelona, Not set

Hospital General Universitario Gregorio Maranon, Madrid, Not set

Md Anderson Cancer Center Madrid Spain, Madrid, Not set

Hospital Universitario Fundacion Jimenez Diaz, Madrid, Not set

Hospital Universitario La Paz, Madrid, Not set

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Not set

Hospital Clinico Universitario de Valencia, Valencia, Not set

Sahlgrenska University Hospital Hematology, Goteborg, Not set

Karolinska Universitetssjukhuset Solna, Stockholm, Not set

Uppsala Akademiska Sjukhus, Uppsala, Not set

Ankara University, Abidinpaa, Not set

Dr Abdurrahman Yurtaslan Research and Training Hospital, Ankara, Not set

Dokuz Eylul University, Balcova, Not set

Erciyes University, Kayseri, Not set

Sakarya Training and Research Hospital, Sakarya, Not set

Ondokuz Mayis University, Samsun, Not set

Edinburgh Cancer Centre, Edinburgh, Not set

Churchill Hospital Oxford University Hospital Nhs Trust, Headington, Not set

St Jamess University Hospital, Leeds, Not set

Freeman Hospital, NewCastle Upon Tyne, Not set

Nottingham University Hospitals Nhs Trust, Nottingham, Not set

Derriford Hospital, Plymouth, Not set

Conditions: B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma, Non-hodgkin Lymphoma, Waldenström Macroglobulinemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Diffuse Large B Cell Lymphoma

Learn More ›

Enhancing the Effects of Alcohol Treatment With L-Carnitine

NCT05355311

Recruiting

The primary objective of this study is to evaluate the effects of L-carnitine, 2.97g daily on alcohol cue-elicited alcohol craving during a human laboratory paradigm after 4 weeks of daily dosing among participants ages 18-25 with alcohol use disorder (AUD) as confirmed by the Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition (DSM-5™) and who report at least mild depressive symptoms on the Beck Depression Inventory-II. Secondary objectives include evaluation of L-carnitine (2... Read More

Gender:

ALL

Ages:

Between 18 years and 25 years

Trial Updated:

04/10/2025

Locations: Brown University, Providence, Rhode Island

Conditions: Alcohol Use Disorder

Learn More ›

Cognition and Imaging With Tigertriever

NCT05531461

Recruiting

The objective of the COGNITIVE Study is to evaluate whether successful reperfusion with Tigertriever is associated with cognitive benefit.

Gender:

ALL

Ages:

Between 18 years and 75 years

Trial Updated:

04/10/2025

Locations: University of California, Los Angeles, California +1 locations

Conditions: Stroke

Learn More ›

Effects of Stereotype Threat on Impulsivity and Its Relation to Alcohol Use in African Americans: An fMRI Study

NCT05675332

Recruiting

The purpose of this study is to investigate the behavioral and neural correlates of stress exposure. Results from this study will enrich the understanding of how sociocultural, behavioral, and neural factors combine to influence alcohol use.

Gender:

ALL

Ages:

Between 21 years and 35 years

Trial Updated:

04/10/2025

Locations: Icahn School of Medicine at Mount Sinai, New York, New York

Conditions: Alcohol Drinking

Learn More ›

A Study of GC012F (AZD0120), a CAR T Therapy Targeting CD19 and BCMA in Subjects With Relapsed/Refractory Multiple Myeloma

NCT05850234

Recruiting

This trial is a phase 1b/2, open-label, multicenter study of GC012F (AZD0120), a CD19/BCMA dual CART-cell therapy, in adult subjects with relapsed/refractory Multiple Myeloma.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/10/2025

Locations: Research Site, Birmingham, Alabama +35 locations

Research Site, Birmingham, Alabama

Research Site, Phoenix, Arizona

Research Site, La Jolla, California

Research Site, Los Angeles, California

Research Site, San Francisco, California

Research Site, Aurora, Colorado

Research Site, Denver, Colorado

Research Site, Jacksonville, Florida

Research Site, Miami, Florida

Research Site, Tampa, Florida

Research Site, Atlanta, Georgia

Research Site, Chicago, Illinois

Research Site, Iowa City, Iowa

Research Site, Boston, Massachusetts

Research Site, Ann Arbor, Michigan

Research Site, Detroit, Michigan

Research Site, Minneapolis, Minnesota

Research Site, Rochester, Minnesota

Research Site, Omaha, Nebraska

Research Site, Buffalo, New York

Research Site, New York, New York

Research Site, Stony Brook, New York

Research Site, Charlotte, North Carolina

Research Site, Durham, North Carolina

Research Site, Nashville, Tennessee

Research Site, Austin, Texas

Research Site, Dallas, Texas

Research Site, Houston, Texas

Research Site, Salt Lake City, Utah

Research Site, Charlottesville, Virginia

Research Site, Edmonds, Washington

Research Site, Seattle, Washington

Research Site, Milwaukee, Wisconsin

Conditions: Relapsed/ Refractory Multiple Myeloma

Learn More ›

A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia

NCT05952037

Recruiting

This study will evaluate the safety and efficacy of the BCL2 inhibitor sonrotoclax (BGB-11417) in participants with relapsed/refractory Waldenström's Macroglobulinemia (R/R WM) and in combination with zanubrutinib in adult participants with previously untreated WM.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/10/2025

Locations: City of Hope National Medical Center, Duarte, California +71 locations

City of Hope National Medical Center, Duarte, California

Colorado Blood Cancer Institute, Denver, Colorado

Medstar Georgetown University Hospital, Washington, District of Columbia

University of Miami, Miami, Florida

Northwestern Medicine Cancer Center, Warrenville, Illinois

Mission Cancer and Blood, Waukee, Iowa

University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland

Dana Farber Cancer Institute, Boston, Massachusetts

Mayo Clinic Rochester, Rochester, Minnesota

Hattiesburg Hematology and Oncology Clinic, Hattiesburg, Mississippi

Memorial Sloan Kettering Cancer Center Mskcc, New York, New York

Atrium Health Levine Cancer Institute (Lci), Charlotte, North Carolina

Ohio State University Comprehensive Cancer Center, Columbus, Ohio

Ut Southwestern Medical Center, Dallas, Texas

Huntsman Cancer Institute, Salt Lake City, Utah

Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia

University of Washington, Seattle, Washington

Concord Repatriation General Hospital, Concord, New South Wales

Genesiscare North Shore, St Leonards, New South Wales

Princess Alexandra Hospital, Woolloongabba, Queensland

Flinders Medical Centre, Bedford PK, South Australia

Monash Health, Clayton, Victoria

St Vincents Hospital Melbourne, Fitzroy, Victoria

Linear Clinical Research, Nedlands, Western Australia

Royal Perth Hospital, Perth, Western Australia

Cross Cancer Institute, Edmonton, Alberta

Lions Gate Hospital Chemotherapy Clinic, North Vancouver, British Columbia

Qeii Health Science Center, Halifax, Nova Scotia

Princess Margaret Cancer Centre, Toronto, Ontario

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian

Guangdong Provincial Peoples Hospital, Guangzhou, Guangdong

Henan Cancer Hospital, Zhengzhou, Henan

Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei

Yancheng First Peoples Hospital, Yancheng, Jiangsu

Shengjing Hospital of China Medical Universityshenbei Branch, Shenyang, Liaoning

The Affiliated Hospital of Qingdao University Branch South, Qingdao, Shandong

Affiliated Zhongshan Hospital of Fudan University, Shanghai, Shanghai

The Third Peoples Hospital of Datong, Datong, Shanxi

Institute of Hematology and Hospital of Blood Disease, Tianjin, Tianjin

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang

The First Hospital of Jiaxing, Jiaxing, Zhejiang

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang

Centre Hospitalier Universitaire Damiens Hopital Sud, Amiens Cedex, Not set

Chu Clermont Ferrand Therapie Cellulaire and Hematolo, Clermontferrand, Not set

Institut Paoli Calmettes, Marseille, Not set

Hopital de La Pitie Salpetriere, Paris, Not set

Chu Hopital Lyon Sud, PierreBenite, Not set

Hopital Robert Debre, Reims, Not set

General Hospital of Athens Alexandra, Athens, Not set

Irccs Azienda Ospedaliero Universitaria Bologna, Bologna, Not set

Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia, Brescia, Not set

Istituto Europeo Di Oncologia, Milano, Not set

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milano, Not set

Irccs Policlinico San Matteo, Universita Degli Studi Di Pavi, Pavia, Not set

Fondazione Policlinico Universitario Agostino Gemelli, Roma, Not set

Azienda Sanitaria Universitaria Friuli Centrale Presidio Ospedaliero Universitario Santa Maria Del, Udine, Not set

Hospital Universitario Vall Dhebron, Barcelona, Not set

Institut Catala Doncologia, Barcelona, Not set

Hospital Clinic de Barcelona, Barcelona, Not set

Hospital Universitario Fundacion Jimenez Diaz, Madrid, Not set

Hospital Universitario de Salamanca, Salamanca, Not set

Hospital Universitario Virgen Del Rocio, Sevilla, Not set

Hospital Universitari Mutua Terrassa, Terrassa, Not set

University Hospitals Dorset, Bournemouth, Not set

Beatson West of Scotland Cancer Centre, Glasgow, Not set

Churchill Hospital Oxford University Hospital Nhs Trust, Headington, Not set

Nhs Highland, Inverness, Not set

St Jamess University Hospital, Leeds, Not set

University College Hospital, London, Not set

The Christie Nhs Foundation Trust Manchester, Manchester, Not set

Plymouth Hospitals Nhs Trust, Plymouth, Not set

Royal Marsden Nhs Foundation Royal Marsden Hospital, Sutton, Not set

Conditions: Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory

Learn More ›

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

NCT06121297

Recruiting

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Gender:

ALL

Ages:

Between 18 years and 65 years

Trial Updated:

04/10/2025

Locations: University of California Irvine, Orange, California +21 locations

Conditions: Systemic Lupus Erythematosus, Lupus Nephritis

Learn More ›